Logo

American Heart Association

  14
  0


Final ID: MP613

Ethnic disparities in the effectiveness of electronically delivered nudges to increase influenza vaccination uptake: A secondary analysis of the NUDGE-FLU-CHRONIC trial

Abstract Body (Do not enter title and authors here): Background: Persistent racial and ethnic disparities exist in influenza vaccination coverage. Increasing uptake in this population could potentially reduce influenza infection and associated complications in a at-risk population.

Purpose: To explore differences in the effectiveness of behavioral nudges on influenza vaccination rates according to ethnicity.

Methods: We conducted a secondary analysis of the nationwide, pragmatic, registry-based, randomized, implementation trial NUDGE-FLU-CHRONIC, which evaluated the effect of 6 different electronic nudging letter strategies on influenza uptake compared with usual care among persons aged 18-64 years, with a chronic disease associated with an increased risk of adverse influenza-related outcomes. Ethnicity was categorized into two groups, white or non-white. Effect modification by ethnicity was tested on the absolute scale. Absolute differences and relative risks (RR) for each comparison were calculated at a significance level of 0.0071.

Results: Of 299,881 participants (53.2% female, median age 52.0 years [IQR, 39.8-59.0]) randomized, 90.4% were white. Vaccination uptake was significantly lower compared with non-whites (22.0% vs. 37.7%, p<0.001). White residents were older (median [IQR] age: 52.5 [40.5, 59.2] vs. 46.6 [36.0, 55.8]), and had a higher prevalence of heart failure (4.0% vs 2.7%, p<0.001), atrial fibrillation (6.9% vs 3.2%, p<0.001, and hypertension (36.2% vs 28.9, p<0.001), whereas non-whites had a higher prevalence of ischemic heart disease (10.5% vs. 8.9%, p<0.001), and diabetes (24.6% vs. 18.7%, p<0.001). White residents were more likely to be educated, be employed, and had higher income (all p<0.001).

Each letter successfully increased influenza vaccination irrespective of ethnicity; however, the magnitude of effectiveness of each letter was significantly modified by ethnicity (Figure 1; all p<0.001), such that effectiveness was less pronounced among non-whites with the largest difference in effect size observed with the repeated letter and the smallest difference in effect size observed with the cardiovascular gain letter.

Conclusion: Electronic nudging letters consistently led to clinically relevant relative gains in vaccine uptake, irrespective of ethnicity. However, absolute gains from these nudging strategies were somewhat attenuated in non-white residents. These results highlight the need for greater emphasis on vaccine implementation strategies tailored according to ethnicity.
  • Bartholdy, Katja  ( Gentofte Hospital , Hellerup , Denmark )
  • Claggett, Brian  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Solomon, Scott  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Kober, Lars  ( RIGSHOSPITALET , Copenhagen , Denmark )
  • Larsen, Carsten  ( Aarhus University , Aarhus , Denmark )
  • Jensen, Jens-ulrik Stæhr  ( Respiratory Medicine Section , Hellerup , Denmark )
  • Biering-srensen, Tor  ( DEPARTMENT OF CARDIOLOGY GENTOFTE , Charlottenlund , Denmark )
  • Dyrby Johansen, Niklas  ( Gentofte Hospital , Hellerup , Denmark )
  • Janstrup, Kira Hyldekær  ( Gentofte Hospital , Hellerup , Denmark )
  • Vaduganathan, Muthiah  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Bhatt, Ankeet  ( Kaiser Permenante , San Francisco , California , United States )
  • Modin, Daniel  ( Gentofte Hospital , Hellerup , Denmark )
  • Wadhera, Rishi  ( Beth Israel Deaconess Medical Centr , Cambridge , Massachusetts , United States )
  • Kazi, Dhruv  ( BIDMC , Boston , Massachusetts , United States )
  • Van Spall, Harriette  ( McMaster University , Hamilton , Ontario , Canada )
  • Author Disclosures:
    Katja Bartholdy: DO have relevant financial relationships ; Research Funding (PI or named investigator):Danish Cardiovascular Academy:Active (exists now) | Brian Claggett: No Answer | Scott Solomon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GSK, Ionis, Lilly,NIH/NHLBI, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI:Active (exists now) ; Consultant:Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, Askbio, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Intellia, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Valo, Synhale, Recordati:Active (exists now) | Lars Kober: DO have relevant financial relationships ; Speaker:Astra Zeneca:Past (completed) ; Speaker:Novo:Past (completed) ; Speaker:Novartis:Past (completed) ; Speaker:Boehringer:Past (completed) | Carsten Larsen: No Answer | Jens-Ulrik Stæhr Jensen: No Answer | Tor Biering-Srensen: No Answer | Niklas Dyrby Johansen: No Answer | Kira Hyldekaer Janstrup: DO NOT have relevant financial relationships | Muthiah Vaduganathan: DO have relevant financial relationships ; Consultant:American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Bristol Myers Squibb, Boehringer Ingelheim, Chiesi, Cytokinetics, Esperion, Fresenius Medical Care, Idorsia Pharmaceuticals, Lexicon Pharmaceuticals, Merck, Milestone Pharmaceuticals, Novartis, Novo Nordisk, Pharmacosmos, Relypsa, Roche Diagnostics, Sanofi and Tricog Health:Active (exists now) ; Research Funding (PI or named investigator):Amgen, AstraZeneca, Boehringer Ingelheim, Galmed, Novartis, Bayer AG, Occlutech, Pharmacosmos, and Impulse Dynamics:Active (exists now) | Ankeet Bhatt: DO have relevant financial relationships ; Consultant:AstraZeneca:Past (completed) ; Consultant:Merck:Active (exists now) | Daniel Modin: No Answer | Rishi Wadhera: DO have relevant financial relationships ; Consultant:Abbott Vascular:Past (completed) | Dhruv Kazi: DO NOT have relevant financial relationships | Harriette Van Spall: DO have relevant financial relationships ; Consultant:Astra Zeneca:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Roche:Active (exists now) ; Other (please indicate in the box next to the company name):Novartis - Educational Account:Past (completed) ; Consultant:Medtronic:Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic - Clinical Trial Executive Committee Role:Active (exists now) ; Research Funding (PI or named investigator):Heart and Stroke Foundation of Canada:Past (completed) ; Other (please indicate in the box next to the company name):Colorado Prevention Center Clinical Research - Clinical Trial Executive Committee Role:Active (exists now) ; Other (please indicate in the box next to the company name):CardioVascular Research Foundation - Clinical Trial Events Committee:Active (exists now) ; Research Funding (PI or named investigator):Canadian Institutes of Health Research:Active (exists now) ; Other (please indicate in the box next to the company name):Boehringer Ingelheim Pharmaceuticals, Inc - Educational Account:Past (completed) ; Consultant:Bayer:Active (exists now) ; Other (please indicate in the box next to the company name):Bayer - Advisory Board:Active (exists now) ; Consultant:Baim Institute for Clinical Research:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

From Systems to Solutions: Innovation, Equity, and Implementation at the Frontlines of Cardiovascular Care

Saturday, 11/08/2025 , 10:45AM - 11:55AM

Moderated Digital Poster Session

More abstracts on this topic:
Association of anthropometric measurements and cardiometabolic risk in Mexican American children

Samuel Joyce, Lee Kyung Hyun, North Kari, Below Jennifer, Lee Miryoung, Mccormick Joseph B, Fisher-hoch Susan

A Community-Based Intervention to Improve Cardiovascular Health Understanding in the Dallas-Fort Worth South Asian Community

Deo Parminder, Rohatgi Anand, Sharma Parul, Sathyamoorthy Mohanakrishnan

More abstracts from these authors:
Electronic Nudges to Increase Influenza Vaccination among Patients with History of Myocardial Infarction: Insights from 3 Randomized Clinical Trials Enrolling >2 Million Patients

Bhatt Ankeet, Sivapalan Pradeesh, Jensen Jens, Martel Cyril, Krause Tyra Grove, Biering-srensen Tor, Johansen Niklas, Vaduganathan Muthiah, Pareek Manan, Modin Daniel, Claggett Brian, Janstrup Kira Hyldekær, Kober Lars, Solomon Scott

Influenza vaccination and risk of cardiovascular events: An instrumental variable analysis of >600,000 participants from the NUDGE-FLU-CHRONIC 1 and 2 trials

Modin Daniel, Janstrup Kira Hyldekær, Larsen Carsten, Larsen Lykke, Wiese Lothar, Dalager-pedersen Michael, Kober Lars, Solomon Scott, Sivapalan Pradeesh, Jensen Jens-ulrik Stæhr, Martel Cyril, Johansen Niklas, Krause Tyra Grove, Biering-srensen Tor, Angrist Joshua D., Yeh Robert, Wadhera Rishi, Vaduganathan Muthiah, Bhatt Ankeet, Chatur Safia, Claggett Brian

You have to be authorized to contact abstract author. Please, Login
Not Available